Supramolecular Enzyme-Peptide Gels for Localized Therapeutic Biocatalysis

Madeline Fuchs,Dillon Seroski,Bethsymarie Soto Morales,Lucas Melgar,Giannia Scibilio,Abigail Ziegler,Renjie Liu,Benjamin Keselowsky,Gregory Hudalla
DOI: https://doi.org/10.1101/2024.09.06.611628
2024-09-08
Abstract:Enzyme therapeutics are often compromised by poor accumulation within target tissues, necessitating high doses that can exacerbate off-target effects. We report an injectable supramolecular enzyme-peptide gel platform for prolonged local enzyme retention . The gel is based on CATCH(+/-) ( o- ssembling ags based on arge-complementarity), cationic and anionic peptide pairs that form β-sheet fibrils upon mixing . Enzymes recombinantly fused to CATCH(-) peptide integrate into CATCH(+/-) β-sheet fibrils during assembly, resulting in an enzyme-peptide gel. Catalytically-active gels were fabricated with four disparate enzymes: CATCH(-)-NanoLuc luciferase, CATCH(-)-cutinase, CATCH(-)-uricase, and CATCH(-)-adenosine synthase A. CATCH(-)-cutinase gels demonstrated tunability of the platform, while CATCH(-)-NanoLuc gels demonstrated prolonged tissue retention relative to soluble enzyme. CATCH(-)-uricase gels resolved localized inflammation in a gout model, while CATCH(-)-adenosine synthase A gels suppressed localized lipopolysaccharide-induced inflammation. Modular and tunable enzyme content, coupled with prolonged tissue retention, establish CATCH enzyme-peptide gels as a generalizable vehicle for effective local therapeutic biocatalysis.
Bioengineering
What problem does this paper attempt to address?